Ignite Creation Date:
2024-05-06 @ 7:20 PM
Last Modification Date:
2024-10-26 @ 3:05 PM
Study NCT ID:
NCT05979220
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-08-07
First Post:
2023-05-19
Brief Title:
Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy
Sponsor:
Shuangyue Liu
Organization:
West China Hospital
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords: